Common Contracts
2 similar United States License and Collaboration Agreement contracts by Transcept Pharmaceuticals Inc
EX-10.1 2 dex101.htm U.S. LICENSE AND COLLABORATION AGREEMENT - PURDUE PHARMACEUTICAL PRODUCTS L.P. CONFIDENTIAL UNITED STATES LICENSE AND COLLABORATION AGREEMENT by and between TRANSCEPT PHARMACEUTICALS, INC. and PURDUE PHARMACEUTICAL PRODUCTS L.P. PAGEUnited States License and Collaboration Agreement • May 5th, 2020
UNITED STATES LICENSE AND COLLABORATION AGREEMENT by and between TRANSCEPT PHARMACEUTICALS, INC. and PURDUE PHARMACEUTICAL PRODUCTS L.P.United States License and Collaboration Agreement • November 16th, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations
THIS UNITED STATES LICENSE AND COLLABORATION AGREEMENT (the “Agreement”) is entered into as of the 31st day of July, 2009 (the “Effective Date”) by and between TRANSCEPT PHARMACEUTICALS, INC., a Delaware corporation having its principal offices at 1003 W. Cutting Blvd, Suite #110, Pt. Richmond, California 94804 (“Transcept”), and PURDUE PHARMACEUTICAL PRODUCTS L.P., a Delaware limited partnership having a place of business at One Stamford Forum, 201 Tresser Boulevard, Stamford, Connecticut 06901-3431 (“Purdue”). Transcept and Purdue are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
